title: [Post hip fracture care].
abstract: Hip fractures are common and associated with high mortality and morbidity. Patients with hip fractures have a high risk of refractures. Osteoporosis is the underlying cause. A therapy with bisphosphonates is indicated without the need of further diagnostic testing with a bone marrow densitometry.
authors.affiliation: Institut für Hausarztmedizin und Versorgungsforschung der Uni Zürich, Universitätsspital Zürich. ryan.tandjung@usz.ch
authors.forename: R
authors.initials: R
authors.lastname: Tandjung
authors.forename: T
authors.initials: T
authors.lastname: Rosemann
mesh_terms: D015502:Absorptiometry, Photon; D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005265:Femoral Neck Fractures / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D058866:Osteoporotic Fractures / Q000175:diagnosis / Q000188:drug therapy*; D055502:Secondary Prevention; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D014807:Vitamin D; D002118:Calcium